World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
23233
World Ranking
16689
National Ranking
549

Overview

Gérard Milano is affiliated with Université Côte d'Azur in France and has contributed extensively to research in medicine and biochemistry, genetics, and molecular biology. Their work primarily focuses on oncology and related subfields, with significant output in cancer research and molecular biology.

Their research covers multiple specific topics, including:

  • Colorectal Cancer Treatments and Studies
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Pancreatic and Hepatic Oncology Research
  • SARS-CoV-2 and COVID-19 Research
  • Cancer Treatment and Pharmacology
  • COVID-19 Clinical Research Studies

Some notable recent publications authored or co-authored by Gérard Milano include:

  • "Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs," 2022, Cancer Science
  • "All You Need to Know About DPYD Genetic Testing for Patients Treated With Fluorouracil and Capecitabine: A Practitioner-Friendly Guide," 2020, JCO Oncology Practice
  • "Host Polymorphisms May Impact SARS-CoV-2 Infectivity," 2020, Trends in Genetics
  • "PD-L1 regulation revisited: impact on immunotherapeutic strategies," 2021, Trends in Molecular Medicine
  • "COVID-19 vaccine race: watch your step for cancer patients," 2020, British Journal of Cancer

Frequent co-authors collaborating with Gérard Milano include:

  • Jocelyn Gal
  • Patrick Brest
  • Baharia Mograbi
  • Paul Hofman
  • Joseph Ciccolini

Their publications appear frequently in journals such as:

  • British Journal of Cancer
  • Trends in Genetics
  • Annals of Oncology
  • Cancer Chemotherapy and Pharmacology
  • International Journal of Molecular Sciences

Best Publications

  • Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value

    Laetitia Marisa;Aurélien de Reyniès;Alex Duval;Alex Duval;Janick Selves

  • Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer.

    O Dassonville;J L Formento;M Francoual;A Ramaioli

  • Population study of dihydropyrimidine dehydrogenase in cancer patients.

    M C Etienne;J L Lagrange;O Dassonville;R Fleming

  • Impact of EGFR expression on colorectal cancer patient prognosis and survival

    J.-P. Spano;C. Lagorce;D. Atlan;G. Milano

  • Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.

    M C Etienne;S Chéradame;J L Fischel;P Formento

  • Management of hypertension in angiogenesis inhibitor-treated patients

    H. Izzedine;S. Ederhy;F. Goldwasser;J.C. Soria

  • A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil.

    A. Beck;M.C. Etienne;S. Chéradame;J.L. Fischel

  • Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas.

    José Santini;Jean-Louis Formento;Mireille Francoual;Gérard Milano

  • Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients.

    Ronald A. Fleming;Gerard Milano;Antoine Thyss;Marie-Christine Etienne

  • Influence of sex and age on fluorouracil clearance.

    G Milano;M C Etienne;E Cassuto-Viguier;A Thyss

  • Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen.

    Antoine Thyss;Johanna Kubar;Gerard Milano;Moise Namer

  • Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity.

    G Milano;M C Etienne;V Pierrefite;M Barberi-Heyob

  • Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate.

    Jean-Pierre Caussanel;Francis Lévi;Silvano Brienza;Jean-Louis Misset

  • Potential Regional Differences for the Tolerability Profiles of Fluoropyrimidines

    Daniel G. Haller;Jim Cassidy;Stephen J. Clarke;David Cunningham

  • Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis

    Dan Rosmarin;Claire Palles;David Church;Enric Domingo

  • Known variant DPYD alleles do not explain DPD deficiency in cancer patients.

    E. S. R. Collie-Duguid;M. C. Etienne;G. Milano;H. L. Mcleod

  • 5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer.

    J Santini;G Milano;A Thyss;N Renee

  • Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives

    J.P. Spano;R. Fagard;J.-C. Soria;O. Rixe

  • Circadian Rhythm-varying Plasma Concentration of 5-Fluorouracil during a Five-Day Continuous Venous Infusion at a Constant Rate in Cancer Patients

    Emmanuel Petit;Gérard Milano;Francis Lévi;Antoine Thyss

  • Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: Phenotypic and genotypic analyses

    Marie-Christine Etienne;Maurice Chazal;Pierre Laurent-Puig;Nicolas Magné

Frequent Co-Authors

Pierre Laurent-Puig
Pierre Laurent-Puig Université Paris Cité
Valérie Boige
Valérie Boige Institut Gustave Roussy
Thierry André
Thierry André Université Paris Cité
Paul Hofman
Paul Hofman Grenoble Alpes University
Frédérique Penault-Llorca
Frédérique Penault-Llorca University of Clermont Auvergne
René Adam
René Adam University of Paris-Saclay
Aimery de Gramont
Aimery de Gramont Grenoble Alpes University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a future in medicine opens doors to many online academic and vocational options beyond the traditional MD path. For working professionals seeking upward mobility, online DNP programs are gaining popularity. Some dnp programs without dissertation allow for an efficient, research-focused approach that can be completed while balancing work and personal life.

If you want to start your healthcare career quickly, lpn online programs are an accessible option. These fast-track programs address a high demand for allied health professionals and are designed for speedy entry to the workforce.

Specialized nursing is another area with strong online pathways. Mental health is a growing field, and the fastest pmhnp program choices can help nurses become certified Psychiatric Mental Health Nurse Practitioners in less time.

Not all routes require clinical practice. For those interested in leadership, the cheapest online healthcare administration degree options make pursuing a management role in healthcare accessible and affordable.

Best Scientists Citing Gérard Milano

Trending Scientists